An oxidative way of UA degradation concerning myeloperoxidase and hydrogen peroxide has been described in the case of cardiovascular disease [21] and PAR has been found to inhibit this enzymatic system [16]. The gene discussed is MPO; the disease is cardiovascular disorder.